Blood sample optimization system and blood contaminant sequestration device and method

The blood isolation device addresses blood culture contamination by isolating the initial blood aliquot using air-permeable barriers and patient pressure, ensuring accurate results and reducing healthcare costs.

JP2024156770AActive Publication Date: 2024-11-06KURIN INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2024121200
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2016-12-27
Filing Date
2024-07-26
Publication Date
2024-11-06
Estimated Expiration
2037-12-27

AI Technical Summary

Technical Problem

Blood culture contamination leads to false-positive results, prolongs procedures, increases healthcare costs, and complicates patient management due to improper sampling techniques and venous collapse during blood collection.

Method used

A blood isolation device with an inlet port, isolation chamber, and air-permeable blood barrier that isolates the initial blood aliquot, using the patient's blood pressure to passively collect uncontaminated samples, reducing the risk of skin cell contamination and venous collapse.

Benefits of technology

The device effectively isolates the initial blood aliquot, minimizing contamination and ensuring accurate blood culture results, thereby reducing false positives and associated healthcare costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024156770000001_ABST
    Figure 2024156770000001_ABST
Patent Text Reader

Abstract

To provide systems and methods for reducing blood culture contamination, lysing of cells, and vein collapse.SOLUTION: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.SELECTED DRAWING: Figure 30B
Need to check novelty before this filing date? Find Prior Art

Description

[Background technology]

[0001] Bacteremia is the presence of microorganisms in the blood, whereas sepsis is characterized by fever, tachycardia, and tachycardia. Bacteremia is when there are clinical symptoms and signs such as asymptomatic asphyxia and hypotension. is associated with high mortality, incidence and length of hospitalization and associated costs. , sepsis, fungemia, and other pathogens actually occur in hospitals or other medical facilities and are transmitted through catheters. Blood clots and venipuncture are potential sources of contamination for these pathogens.

[0002] Blood cultures are used to detect microbial pathogens associated with bacteremia and sepsis in patients' blood. The term blood culture refers to the collection of blood in one or more blood culture bottles or refers to a single venipuncture from a peripheral site or a central or arterial line that is inoculated into a container. One bottle is considered one blood culture, two or more are considered a set. The sets are obtained from multiple venipunctures and relate to different sites on the patient.

[0003] These methods address microbial identification and susceptibility testing, which are key components in managing sepsis. However, the lack of rapid results and low sensitivity to fastidious pathogens This has led to the development of improved systems and complementary molecular or proteomic tests. do.

[0004] Obtaining blood samples for blood culture is an important component of modern patient care and requires proper Providing an accurate diagnosis can positively impact patient outcomes and prevent unnecessary antimicrobial therapy. adversely affecting outcomes by prolonging treatment, lengthening hospital stays, and increasing costs This may also occur.

[0005] One consequence of blood culture collection is contamination. Contamination of blood cultures can lead to false-positive culture results and Contamination of blood cultures can result in significant increases in infection and / or healthcare costs. These include improper skin preparation, improper disinfection of collection tubes, and contamination of the initial blood draw, all of which may result in It may be distorted.

[0006] Blood culture collection kits are commonly provided by companies such as BD, Smith & B. Braun, etc. "butterfly" sets, infusion sets, or other types of venipuncture devices, preferably The blood culture bottles consist of aerobic and anaerobic blood culture bottles. Various different bottles were also examined. These bottles are available for both aerobic and anaerobic collection. Specially designed to optimize yield. Conventional kits use a single bottle. Commonly known as a "Vacutainer®," it is used to hold a predetermined amount of blood or other liquid. A sterile tube with a lid that can be evacuated to create a vacuum inside the tube to facilitate collection of the fluid. A blood collection tube made from glass or sterile plastic tubing.

[0007] False-positive blood cultures are commonly the result of poor sampling techniques. They include: This leads to unnecessary antibiotic use, increasing hospital costs and patient anxiety. The blood sample is taken by sticking a needle into the skin and then using a Vacutainer to capture the blood sample. Contamination can occur due to inappropriate or inappropriate exposure of the puncture site and surrounding skin area. can result from incomplete disinfection. It can also result from the needle penetrating the skin during insertion. This occurs when excised skin cells and associated contaminants are drawn into the sample. It also says:

[0008] Blood flow through a hypodermic needle is laminar, so when a pressure drop is applied across the hypodermic needle When blood is drawn strongly or a very small subcutaneous injection is made, a flow velocity gradient is generated across the flow tube. The use of a needle causes lysis and release of potassium from red blood cells, which in turn reduces the amount of blood samples. The pull may be abnormal.

[0009] In other instances, some patients have delicate veins, which may be particularly problematic for the patient's condition. Pressure drops or shock waves, such as those caused by a syringe plunger being withdrawn too quickly can decay in a vacuum. Since such a state is impossible to know in advance, Such venous collapse is dangerous and very difficult to control.

[0010] To reduce the rate of blood culture contamination, e.g., training of staff in sterile collection technique Various strategies have been implemented, including feedback on contamination rates and the introduction of blood culture collection kits. Skin disinfection can reduce the risk of contamination, but it is still possible that more than 20% of skin microorganisms may be infected. The object is located deep in the dermis and is not affected by disinfection. It is not recommended to change the needle before bottle inoculation. , is not recommended as it increases the risk of needlestick injury without reducing contamination rates.

[0011] Some conventional systems and techniques for reducing blood culture contamination include the use of central venous catheters. Discard the first aliquot of blood drawn from catheters, venipunctures, and other vascular access systems. However, these systems involve the user mechanically controlling the intravascular device. It requires a complex series of steps that are difficult to operate efficiently or that are difficult to ensure. It is necessary to do so. Summary of the Invention [Problem to be solved by the invention]

[0012] Disclosed herein is a system and method for reducing blood culture contamination, cell lysis, and venous collapse. In some implementations, the systems and methods provide for stabilizing user disinfection variability. This eliminates the risk of skin cells being introduced into the blood culture sample. The systems and methods disclosed herein include a catheter for collecting a contaminant-free blood sample. When to attach the Cyutainer® or other blood collection device (i.e., syringe) It does not require any changes to existing clinical processes other than potentially demonstrating how well the treatment can be used.

[0013] In some implementations of the systems and methods disclosed herein, blood sampling is performed to measure the patient's own blood pressure. This is achieved passively through the use of The system and method eliminates additional user steps beyond the user's normal work. The catheter can be adapted to fit a butterfly venipuncture system. It can also be used with samples taken through a catheter. [Means for solving the problem]

[0014] In one aspect, a blood isolation device is provided. The blood isolation device includes an inlet port and The blood isolation device includes an isolation chamber connected to an inlet port and an outlet port. The blood isolation device further includes an isolation chamber having an air vent that includes an air permeable blood barrier. The vice has a proximal end connected to the inlet port and a distal end connected to the outlet port. , further comprising a sampling channel.

[0015] In another aspect, a blood isolation device is described that is connected to a blood collection pathway. The blood isolation device is connected to the patient needle and a sample collection device. an inlet port; and an isolation chamber connected to the inlet port, the isolation chamber having an air permeable blood barrier. and an isolation chamber having a vent port. The blood isolation device is connected to the inlet port. a sampling channel having a proximal end connected to a distal end of the sampling channel and a sample collection device; The device further includes an outlet port connected to the seat.

[0016] In yet another aspect, a blood isolation device for connection with a blood collection system is described. The blood collection system consists of a patient needle to allow a blood sample to be drawn from the patient, and a sealed and a sample needle adapted to receive an evacuated blood collection tube. includes an inlet port that is connected to a patient needle for receiving a blood sample from a patient. The blood isolation device has a vent connected to the inlet port and including an air permeable blood barrier. An isolation chamber for sampling blood before the sample needle is opened by the vacuum blood collection tube. The blood isolation device further includes an isolation chamber for receiving and isolating a first portion of the sample. The inlet port is connected to a sampling channel having a proximal end, the sampling channel being connected to a vacuum blood collection tube. Thus, when the sample needle is opened, the sampling flow path carrying the subsequent portion of the blood sample is opened. The blood isolation device includes a catheter for conveying a subsequent portion of the blood sample to a sample needle. The sampling channel further includes an outlet port connected to a distal end of the sampling channel.

[0017] In yet another aspect, a blood sample optimization system is disclosed and described. The sample optimization system enables one or more samples of a patient's blood to be drawn and blood collection system to obtain blood from patients who may be contaminated by the venipuncture process and One or more samples of the patient's blood may result in false-positive identification of pathogens in the patient's blood. and a blood isolation device for receiving and isolating an initial portion of the blood.

[0018] A blood sampling system involves venipuncture of a patient to allow a sample of the patient's blood to be drawn. a patient needle configured for receiving a blood sample; a blood collection path connected to the patient needle for carrying a blood sample; configured to receive an evacuated blood collection container for collecting and storing a subsequent portion of the fluid sample. and a sample needle formed therein.

[0019] In yet another aspect, a blood isolation device is disclosed and described. The blood isolation device includes an inlet port, an outlet port connected to the inlet port, and a blood supply port connected to the inlet port. and a separation chamber connected to the blood vessel. The separation chamber may include an air permeable blood vessel. It may have vents including a rear.

[0020] In one embodiment, the blood isolation device includes an inlet port, an outlet port, and an inlet through a branch point. a separation chamber connected to the inlet port and a proximal end connected to the inlet port via a branch point; and a sampling channel having a distal end connected to the outlet port. The chamber has a vent that includes an air-permeable blood barrier, and the vent reduces the air-permeable blood barrier. The vent is defined by an exterior wall that at least partially surrounds the device and includes one or more air holes, and the vent is disposed in the wall. and an air permeable cap that prevents air from entering the isolation chamber. In certain related aspects, the isolation channel further comprises a one-way seal adjacent the protective blood barrier. The chamber, the sampling channel and the branch point are configured to direct a first portion of blood to the isolation chamber for isolation. A second portion of the blood flows into the isolation chamber toward the air-permeable blood barrier to isolate the blood. a first portion of the blood separated within the separation chamber and directed toward the outlet port; The sample flow path is sized and configured to be guided by a sample nozzle.

[0021] In another embodiment, the sampling flow path and the branch point are configured to direct the first portion of the blood to the isolation chamber. The isolation chamber is filled with blood, and the air in the isolation chamber is expelled through the vent hole. the second portion bypasses the isolation chamber and the first portion of the blood isolated within the isolation chamber; The sampling flow path is sized and configured to be directed toward the outlet port.

[0022] In certain embodiments, the blood isolation and sampling system isolation device includes a patient The needle is connected to a blood collection channel having a sample collection device at a distal end, and a proximal end and a distal end of the blood collection channel. and a blood isolation device attached to the blood collection pathway between the blood collection pathway and the blood collection pathway. The blood isolation device has an inlet port facing the patient needle and connected to the blood collection line, and a sump. The outlet port faces the blood collection device and is connected to the blood collection path, and the inlet port is connected to the blood collection path via a branch point. a separation chamber connected to the inlet port through a branch point and a proximal end connected to the outlet port through a branch point; and a sampling channel having a distal end connected to the port, The catheter has a vent including an air-permeable blood barrier, the vent reducing the air-permeable blood barrier. the vent is defined by an exterior wall at least partially surrounding the wall and including one or more air holes; a cap that at least partially covers the isolation chamber and is air permeable to prevent air from entering the isolation chamber; In certain related aspects, the isolation chamber further comprises a one-way seal adjacent the blood barrier. The first portion of the blood is passed to the isolation chamber for isolation. A second portion of the blood flows into the isolation chamber toward the air permeable blood barrier. The first portion of the blood separated in the separation chamber is directed toward the outlet port. The sample flow path can be sized and configured to be guided by a filter to the sampling flow path.

[0023] The blood isolation device is connected along the blood collection pathway between the patient needle and the sample needle and is adapted to isolate blood from the patient needle and the sample needle. The blood isolation device includes an inlet port for receiving the sample. a separation chamber connected to the inlet port for receiving an initial amount of the blood sample; a vent including an air permeable blood barrier to isolate at least a first portion of the first amount of The blood isolation device further includes an isolation chamber having a proximal a sampling flow path having an end, the isolation chamber being adapted to receive at least a first volume of the blood sample; Sampling involves isolating the first portion of the blood sample and transporting subsequent amounts of the blood sample to a vacuum blood collection container. The blood isolation device further includes a flow path. The blood isolation device includes an outlet port connected to a distal end of the sampling flow path. the outlet port further comprising an outlet port for outputting a subsequent volume of the blood sample.

[0024] The details of one or more embodiments are set forth in the accompanying drawings and the description below. and advantages will become apparent from the description and drawings, and from the claims. [Brief description of the drawings]

[0025] These and other aspects are described in detail below with reference to the following drawings:

[0026] [Figure 1] 1 shows a blood sample optimization system.

[0027] [Diagram 2] 1 illustrates a blood sample optimization system according to an alternative implementation.

[0028] [Diagram 3] 1 illustrates a blood sample optimization system according to another alternative implementation.

[0029] [Figure 4] 1 illustrates a blood sample optimization system according to another alternative implementation.

[0030] [Diagram 5] 1 illustrates a blood sample optimization system according to another alternative implementation.

[0031] [Figure 6] 1 illustrates a blood sample optimization system according to an alternative implementation.

[0032] [Figure 7] 1 is a flow chart of a method for optimizing blood culture quality.

[0033] [Figure 8A] 1 illustrates a blood isolation system for non-contamination blood collection according to some implementations. [Figure 8B] 1 illustrates a blood isolation system for non-contamination blood collection according to some implementations. [Figure 8C] 1 illustrates a blood isolation system for non-contamination blood collection according to some implementations. [Figure 8D] 1 illustrates a blood isolation system for non-contamination blood collection according to some implementations. [Figure 8E] 1 illustrates a blood isolation system for non-contamination blood collection according to some implementations.

[0034] [Figure 9] 1 illustrates a path splitter for use in a blood isolation system.

[0035] [Figure 10A] 1 illustrates a blood isolation system for non-contaminated blood collection according to an alternative embodiment. [Figure 10B] 1 illustrates a blood isolation system for non-contaminated blood collection according to an alternative embodiment. [Figure 10C] 1 illustrates a blood isolation system for non-contaminated blood collection according to an alternative embodiment. [Figure 10D] 1 illustrates a blood isolation system for non-contaminated blood collection according to an alternative embodiment.

[0036] [Figure 11A] 1 illustrates a blood isolation system for non-contamination blood collection according to another alternative implementation. [Figure 11B] 1 illustrates a blood isolation system for non-contamination blood collection according to another alternative implementation. [Figure 11C] 1 illustrates a blood isolation system for non-contamination blood collection according to another alternative implementation. [Figure 11D] 1 illustrates a blood isolation system for non-contamination blood collection according to another alternative implementation. [Figure 11E] 1 illustrates a blood isolation system for non-contamination blood collection according to another alternative implementation.

[0037] [Figure 12] 12A-12D show a blood sample optimization system including a blood isolation device according to yet another alternative implementation.

[0038] [Figure 13A] 13 illustrates a blood sample optimization system 1300 according to yet another alternative implementation. [Figure 13B] 13 illustrates a blood sample optimization system 1300 according to yet another alternative implementation. [Figure 13C] 13 illustrates a blood sample optimization system 1300 according to yet another alternative implementation. [Figure 13D]13 illustrates a blood sample optimization system 1300 according to yet another alternative implementation.

[0039] [Figure 14A] 1 illustrates yet another implementation of a blood collection system that segregates contaminants from an initial aliquot or sample to reduce false positives in blood cultures or tests performed on a patient's blood sample. [Figure 14B] 1 illustrates yet another implementation of a blood collection system that segregates contaminants from an initial aliquot or sample to reduce false positives in blood cultures or tests performed on a patient's blood sample. [Figure 14C] 1 illustrates yet another implementation of a blood collection system that segregates contaminants from an initial aliquot or sample to reduce false positives in blood cultures or tests performed on a patient's blood sample. [Figure 14D] 1 illustrates yet another implementation of a blood collection system that segregates contaminants from an initial aliquot or sample to reduce false positives in blood cultures or tests performed on a patient's blood sample. [Figure 14E] 1 illustrates yet another implementation of a blood collection system that segregates contaminants from an initial aliquot or sample to reduce false positives in blood cultures or tests performed on a patient's blood sample.

[0040] [Figure 15A] A blood isolation device and method of using the same according to yet another embodiment is provided. [Figure 15B] A blood isolation device and method of using the same according to yet another embodiment is provided. [Figure 15C] A blood isolation device and method of using the same according to yet another embodiment is provided. [Figure 15D] A blood isolation device and method of using the same according to yet another embodiment is provided. [Figure 15E] A blood isolation device and method of using the same according to yet another embodiment is provided. [Figure 15F]A blood isolation device and method of using the same according to yet another embodiment is provided. [Figure 15G] A blood isolation device and method of using the same according to yet another embodiment is provided.

[0041] [Figure 16A] 1 illustrates a blood isolation device according to yet another implementation. [Figure 16B] 1 illustrates a blood isolation device according to yet another implementation. [Figure 16C] 1 illustrates a blood isolation device according to yet another implementation. [Figure 16D] 1 illustrates a blood isolation device according to yet another implementation.

[0042] [Figure 17] 17A-17E show a lower part of a housing for a blood isolation device.

[0043] [Figure 18] 18A-18F show the upper member of a housing for a blood isolation device.

[0044] [Figure 19A] 1 shows a blood isolation device having an upper member that mates with a lower member. [Figure 19B] 1 shows a blood isolation device having an upper member that mates with a lower member.

[0045] [Figure 20] 1 illustrates a blood sample optimization system including a blood isolation device.

[0046] [Figure 21] 1 shows a non-vented blood isolation device using a wicking material chamber.

[0047] [Figure 22A] 1 illustrates a material configuration of a filter for isolating blood within an isolation chamber of a blood isolation device. [Figure 22B]1 illustrates a material configuration of a filter for isolating blood within an isolation chamber of a blood isolation device.

[0048] [Figure 23A] 13 illustrates another implementation of a blood isolation device that uses vacuum force from a blood collection device. [Figure 23B] 13 illustrates another implementation of a blood isolation device that uses vacuum force from a blood collection device. [Figure 23C] 13 illustrates another implementation of a blood isolation device that uses vacuum force from a blood collection device. [Figure 23D] 13 illustrates another implementation of a blood isolation device that uses vacuum force from a blood collection device. [Figure 23E] 13 illustrates another implementation of a blood isolation device that uses vacuum force from a blood collection device.

[0049] [Figure 24A] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 24B] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 24C] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 24D] 1 illustrates another implementation of a blood optimization system and blood isolation device.

[0050] [Figure 25A] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 25B] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 25C] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 25D] 1 illustrates another implementation of a blood optimization system and blood isolation device.

[0051] [Figure 26A] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 26B] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 26C] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 26D] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 26E] 1 illustrates another implementation of a blood optimization system and blood isolation device.

[0052] [Figure 27A] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 27B] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 27C] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 27D] 1 illustrates another implementation of a blood optimization system and blood isolation device.

[0053] [Figure 28A] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 28B] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 28C] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 28D] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 28E] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 28F] 1 illustrates another implementation of a blood optimization system and blood isolation device.

[0054] [Figure 29A] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 29B] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 29C]1 illustrates another implementation of a blood optimization system and blood isolation device.

[0055] [Figure 30A] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 30B] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 30C] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 30D] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 30E] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 30F] 1 illustrates another implementation of a blood optimization system and blood isolation device. [Figure 30G] 1 illustrates another implementation of a blood optimization system and blood isolation device.

[0056] Like numbers in the various drawings indicate like elements. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0057] The present disclosure provides a method for reducing or eliminating contaminants in blood samples taken, thereby improving the quality of blood samples taken. The present invention relates to a blood sample that is subjected to a blood culture or other test to reduce or eliminate false positive results. A liquid sample optimization system and method are described. In some implementations, blood sample optimization is performed. The system includes a patient needle for vascular access to the patient's bloodstream and a Vacutainer ) or other sampling device such as a vacuum blood collection container or vacuum blood collection tube a sample needle for supplying a blood sample to the patient; and a blood sample holder located between the patient needle and the sample needle. The blood isolation device is a device for isolating the first potentially contaminated aliquots of blood from the blood. a separation chamber for separating the first aliquot of blood, Potentially uncontaminated blood between the patient needle and the sample needle after isolation in the chamber The sampling flow path may further include a sampling flow path that bypasses the isolation chamber for carrying the

[0058] FIG. 1 illustrates a blood sample optimization system according to some implementations. The system includes: The patient needle 1 is for piercing the skin to access the patient's vein and blood therein. The system may include a resealable boot 10, a Luer-activated valve, or another collection interface. or a resealable boot 10, a luer-activated valve, or another collection inlet, housed within the device. The sample needle ( i.e., resealably sealed for use with Vacutainers® and the like. The resealable boot 10 further includes a vacutainer for drawing the patient's blood. By using a Nahner bottle (not shown), The system can be configured to press the sample needle 5 around the sample needle 5. The volume chamber 30 may further include an isolation chamber formed by the housing 50. It also includes one or more channels 45 leading into the chamber 55 .

[0059] The isolation chamber 55 is a predetermined or measured amount depending on the volume of the isolation chamber 55. a chamber for receiving and holding an initial aliquot of the patient's blood; The first blood draw is generally slower than subsequent blood draws. All contain or are more likely to contain microorganisms or other pathogens that cause bacteremia and sepsis. The isolation chamber 55 is housed in a rigid housing or is It may be a container formed in or defined by the housing itself, or The isolation chamber 55 can be realized as a tube or a lumen. Regardless of how the device is configured and implemented, the device may have a predetermined volume. , the predetermined volume is based on the volume of the patient needle, i.e., a volume less than the volume of the patient needle. can range from any volume to a volume 20 times larger than the volume of the patient needle. The predetermined volume of the isolation chamber 55 conserves or minimizes the amount of blood that is isolated and disposed of. It can also be set to

[0060] The isolation chamber 55 may be formed, contained, or housed within the chamber housing 50. and may be made of plastic, rubber, steel, aluminum or other suitable materials. For example, the isolation chamber 55 may be formed from a flexible tube or other elastomeric material. The isolation chamber 55 can be configured to allow air to exit the isolation chamber 55. As used herein, an air permeable blood barrier 20 is The term "air" means a substance, material or structure that is air permeable but substantially blood impermeable. Representative examples are hydrophobic membranes and hydrophobic coatings. Hydrophilic membranes or coatings in combination with filtration, meshes, filters, mechanical valves, Antibacterial material or material that prevents air from escaping from the isolation chamber 55 when the isolation chamber 55 fills with blood. In various exemplary embodiments, the present invention may include any other means capable of expelling the In the present invention, the air permeable blood barrier allows air to pass through until it comes into contact with the liquid. It may be formed of one or more materials, such materials being air and / or liquid. In other words, the liquid and Prior to contact with the liquid, the material forms an air permeable barrier. After contact with the liquid, the material The further passage of air and / or liquid is substantially or completely prevented.

[0061] The holes or channels 45 can be of any desired length, cross-sectional shape or size, and / or or may be formed away from the low volume chamber 30 at any desired angle or orientation. The hole or channel 45 also allows the first aliquot of blood sample to be delivered into the isolation chamber 55. In some particular implementations, the one-way flap or valve 60 may be configured to hold the The holes or channels 45 allow for unidirectional blood flow from the low volume chamber 30 to the isolation chamber 55. The blood flow passage may include a "duckbill" or flapper valve 60 for air permeable blood. The barrier 20 is constructed of a material that allows air to escape but seals upon contact with blood. This seal can be used to seal the isolation chamber 55 without allowing outside air to enter the isolation chamber 55. Eliminates the need for valves.

[0062] Valve 60 can be any type of valve or opening and closing mechanism. Chamber 30 is substantially The device is designed to not retain residual blood and to separate a specific volume or percentage of blood from the isolation chamber. Similarly, the isolation chamber 55 may be designed to hold or pass the liquid. 5. Any type of coating, such as an antibacterial coating, or isolated initial collection Coatings that aid in identification and / or diagnosis of blood components may also be included.

[0063] The housings 50 and 40 may be made of acrylonitrile butadiene styrene (ABS) or other Includes plastics such as thermoplastic or polymeric materials, rubber, steel, or aluminum The air permeable blood barrier 20 may be formed from any suitable material. Upon contact with blood or when the air displacement is stopped, or during an event and isolation channel A color-providing substance or other signal that is activated in the event of any combination with blood in the chamber 55. The air permeable barrier may also be adapted to resist fluid flow from an external fluid source, splashes, etc. An external barrier such as a hydrophobic membrane or cover that inhibits or prevents inadvertent or premature sealing of the filter. The isolation chamber 55 also includes a layer that allows the user to know that the chamber is filled. The material may be translucent or transparent to allow visual confirmation of the nature of the material.

[0064] FIG. 2 illustrates a blood sample optimization system according to some alternative implementations. In this embodiment, a segregation chamber 55 or waste chamber surrounds the patient needle 1 and is an open ended container. The housing is connected to the waste chamber and the sample needle housing base and housing The patient needle 1 and the sample needle 5 are connected to each other by a boot 56. The boot 56 defines a continuous blood collection flow path therethrough. The device includes a single hole or flow path leading from the blood collection flow path to the isolation chamber 55. In some embodiments, the nozzle may include a plurality of holes or flow passages. Each hole or flow passage may include a one-way valve. The catheter can be sized and adapted for a given amount of blood flow.

[0065] The isolation chamber 55 contains an air-permeable blood barrier. The filter prevents a volume of blood from entering the isolation chamber. and a sensor or a detector for detecting and / or indicating when the particles are collected in the separation chamber 55. The indication may further include an indicator, such as a Vacutainer®. The user is alerted to attach a vacuum blood collection tube or bottle to the sample needle 5. The housing for the chamber 55 can be of any size or shape, and the Any type of material may be included to define an interior space or volume. Initially, it is filled with air only, but it is then coated with a decontaminant, coagulant, or other agent or substance. When the vacuum blood collection tube is attached to the sample needle 5, the blood is automatically The blood flows into the bottle through the patient needle 1, the blood collection flow path and the sample needle 5. The sample needle 5 Resealable to seal the sample needle when the blood collection bottle is not attached to the sample needle The material is covered by a boot, coating or membrane that is suitable for use in the manufacture of semiconductor devices.

[0066] FIG. 3 illustrates a blood sample optimization system according to some alternative implementations. In the illustrated implementation, The sample needle 5 is surrounded by a resealable boot or membrane and is further connected to the patient needle 1. A blood flow path is formed through the sample needle and the patient needle. The connection between the isolation chamber 104 and the primary blood flow path may be a flow path, port, or opening leading from the primary blood flow path to the isolation chamber 104. The connector 102 includes a "T" or "Y" connector 102.

[0067] The T or Y connector 102 includes a flap or one-way valve to allow for a predetermined flow rate of blood. The isolation chamber 104 is formed from a tube having a hole sized and fitted. Or it can be formed by a rigid housing, which is initially filled with air. The chamber 104 bleeds automatically, i.e., under pressure from the patient's own blood pressure. The isolation chamber 104 is preferably formed of The proximal end of the tube is connected to the T or Y connector 102, and the distal end of the tube is connected to an air permeable blood vessel. The T or Y connector 102 may be configured to accommodate any desired configuration for most efficient blood flow. It can be split at an angle to optimize mixing of the first aliquot of blood with the main blood sample. Minimize or eliminate the interface between the openings and the flow path and the main blood flow path The device can be configured to:

[0068] In some alternative implementations, the sample needle has a T-shaped or can be attached to any length of tubing that connects to the Y connector 102 The isolation chamber 104 may contain any amount of blood sample, so long as the first aliquot contains a predetermined amount of blood sample. The T or Y connector 102 may also be of any shape or volume with respect to the main blood flow path. The air permeable blood barrier can include parallel openings or flow paths. When the air collected in the separation chamber or released reaches a certain threshold, i.e., zero The tube may further include an indicator 107 or other mechanism to indicate when , a clip 109 that can be used to clamp and prevent fluid flow through a tube. may include.

[0069] Once the air permeable blood barrier and primary chamber are sealed, the first aliquot The blood is trapped in a sequestration chamber 104 and a Vacutainer (registered trademark) is inserted into the sequestration chamber 104 to obtain a sample. A vacuum blood collection tube, such as a sample bottle, is attached to the sample needle 5. The blood collection tube can be removed. The sample needle 5 can then be resealed. Once all blood collections are complete, the first aliquot of blood can be With the liquid still trapped in the isolation chamber 104, the system can be discarded.

[0070] FIG. 5 illustrates a blood sample optimization system according to some alternative implementations. In the illustrated implementation, In this case, the sample needle 5 is connected to the patient needle by a tube. 120 may be added at any desired location along the tube, and spaced apart substantially as described above. The separation chamber 204 includes an opening, port, or passageway.

[0071] FIG. 6 illustrates how a separation chamber 304 configured as a primary collection flow path receives an initial aliquot of blood. According to some alternative implementations, a blood sump is provided adjacent to the blood collection flow path. The isolation chamber 304 is adapted to accommodate the blood collection flow path, the patient needle 1 and / or the sample. The primary collection flow path may be a T or Y connector 120, or other terminal. The isolation chamber 304 may include an air permeable blood barrier. The air permeable blood barrier, as described above, is an insulating material that is insulated from fluids such as blood when in contact with the blood. It may also include an indicator.

[0072] In some embodiments, either or both of the patient needle 1 and the sample needle 5 are fitted with a Luer lock male connector. However, various implementations may use a Luer Lock or Luer Lock female connector. The connector at the end of the sample needle of the Blood Sample Optimization System is pressurized with ambient air pressure. and an air outlet of the air permeable blood barrier. The system is first sealed to allow the air to be diverted away. The patient's own blood pressure is then used automatically to overcome the ambient air pressure in the isolation chamber, making it air permeable. The air is forced through the blood barrier, replacing the air in the isolation chamber with blood.

[0073] FIG. 7 is a flow chart of an exemplary method for optimizing blood culture quality. At 702, a clinician inserts a needle into a patient's vein. At 704, blood is pumped into an isolation chamber. The blood flows into the isolation chamber, pushing the air out of the isolation chamber through the air-permeable blood barrier. In some implementations, the volume of the isolation chamber is less than 0.1 cubic centimeters (cc). The isolation chamber is a second chamber for the blood sample. The first portion of a blood sample is more likely to be contaminated than any other subsequent or subsequent collections. The isolation chamber is sized and adapted to accommodate an air-permeable blood barrier. This blood barrier allows air to be expelled by blood pumped from the patient's veins. Therefore, such blood can be stored in a vacutainer for receiving and storing blood samples. necessarily and before being drawn or otherwise entered into the TM or other bottle. It will automatically flow into the isolation chamber.

[0074] When the isolation chamber becomes full, blood enters the air that blocks or prevents blood from passing through. At 706, the blood collects in or otherwise contacts the air permeable barrier. When the air comes into contact with the entire internal surface area of ​​the air-permeable blood barrier, the air-permeable blood barrier closes and the air At 708, the clinician inserts a container such as a Vacutainer®. An indicator is provided to show that a vacuum blood collection tube can be attached or that the tube is full. The indicator shows whether the primary chamber is full or not. Visibility of the primary chamber to confirm, e.g., a color-changing blood barrier or other indicator Since the filling time of the sequestration chamber can be substantially instantaneous, If such an indicator is present, it simply means that the isolation chamber is filled. It is possible that.

[0075] Before the evacuated blood collection tube is attached, communication between the needle, the sampling channel, and the isolation chamber is is restricted by the blood barrier seal of the isolation chamber, so that isolation prevents air from entering the system. The sealing of the communication path shall not allow mechanical twisting or other movement. This is accomplished by means of small holes or tortuous paths and does not require separate valves or mechanical action or Eliminates the need for manipulation by the clinician. When the evacuated blood collection tube is removed at 710, it self-seals. A sealing membrane seals the sample needle and, at 712, a further subsequent evacuated blood collection tube is attached. Once the sample has been taken, the device may be removed from the patient at 714. and discarded.

[0076] 8A-8E illustrate an exemplary blood sample optimization system for non-contaminating blood collection, according to some implementations. The blood sample optimization system 800 includes a tube, a patient needle (or both), and ), or other vascular or venous access device. and a first outlet to an isolation chamber tube 806 and a second outlet to a sample collection tube 808. The isolation chamber tube 806 and the sample One or both of the collection tubes 808 can be formed from tubing. In this embodiment, the isolation chamber tube 806 is configured to accommodate a specific volume of the initial blood sample. The sample collection tube 808 is then sized to fit into the isolation chamber tube 806. When filled, the sample collection tube 808 receives a blood sample. Attaches to a NER® base or housing 810, or other blood sample collection device. It can be continued.

[0077] The blood isolation system 800 further includes a blood isolation device 812. 12 includes a housing 818 as shown in more detail in FIGS. 8B-8D. 8 defines a path for a non-contaminated sample collection tube 808 or has either end non-contaminated. The contaminated sample collection tube 808 includes a sampling channel 820 that is connected to the contaminated sample collection tube 808. The sampling channel 820 is disposed within the housing 818 at a location along the uncontaminated sample collection tube 808. 8. The housing 818 is curved to better secure and stabilize the can be done.

[0078] The blood isolation device 812 is connected to the isolation chamber tube 806 or other chamber. The isolation chamber 822 further includes an air permeable blood barrier 82 4. The air permeable blood barrier 824 also prevents the blood sample (i.e., uncontaminated The completion of blood sampling is an indicator that formal collection of blood samples (stained blood samples) can begin. It can contain colorants that change to different colors when touched properly. It can also contain small light, sound emitting mechanisms, etc. Other indicators may be used. In some implementations, the air permeable blood barrier is Although it is positioned at a right angle from the direction of the isolation chamber 822, it is used for the housing 818. They can be placed at any distance or orientation to save space and materials. The bag 818 and its contents may be formed from any rigid or semi-rigid material or range of materials. It is possible.

[0079] FIG. 9 illustrates a path splitter for use in a blood isolation system such as that shown in FIGS. 8A-8E. Path splitter 900 has an inlet port 902 and a main line outlet port 904. and an isolated flow channel outlet port 906. The inlet port 902 is similarly connected to the patient needle system. The main line outlet port can be connected to a connected main tube or directly to a patient needle. 904 is a mains port to a blood collection system such as a Vacutainer® base or housing. The isolated blood collection system can be connected to the blood collection tube or directly to such a blood collection system. The port 906 receives a first sample of blood up to a measured amount or a predetermined threshold and Alternatively, the isolation channel outlet port can be connected to an isolation tube for isolation. 906 can be connected to the isolation chamber. The isolation channel outlet port 906 is preferably Alternatively, the main line outlet port 904 is bent at an angle of 20 to 70 degrees, while the main line outlet The port 904 is preferably aligned with the inlet port 902. According to the mechanism and technique, a predetermined amount of the initial blood sample is transferred to a separation tube or separation chamber. Once isolated within the blood sample, the subsequent blood sample will flow into the inlet port 902 and into the primary bloodstream without obstruction. It flows directly out of the line outlet port 904 .

[0080] 10A-10D show a blood isolation device 1000 according to another embodiment. The device 1000 has an inlet port 1002, a main outlet port 1004, and an isolated flow path port 1005. 06. The inlet port 1002 may be connected to a patient needle or associated tubing. The main exit port 1004 may be connected to a Vacutainer®, associated tubing, or The isolated flow passage port can be connected to a blood sample collection device such as a Luer-activated valve. A port 1006 separates from the main exit port 1004 into an isolation chamber 1008. In this embodiment, the isolation chamber 1008 is configured as a spiral flow path within a housing or other container 1001. is formed.

[0081] The isolation chamber 1008 has a distal end that is bounded by an air permeable blood barrier 10, substantially as described above. 10. The air in the isolation chamber 1008 passes through an air permeable blood barrier 1010. 1006, and is displaced by the first aliquot of blood introduced into the isolated flow channel port 1006. Once the isolation chamber 1008 is filled, the primary exit port 1004 Further blood samples can be taken and these samples will be uncontaminated.

[0082] 11A-11E show a blood isolation device 1100 according to another alternative implementation. The isolation device 1100 includes an inlet port 1102, similar to the inlet ports described above, and a primary outlet port 1104. 1104 and an isolated flow passage port separated from the main outlet port 1104 and the inlet port 1102. The isolated flow channel port is connected to an isolated chamber 1108. In the implementations shown in 1A-11E, the blood isolation device functions as an isolation chamber 1108. The base member 1101 includes a flow passage therein. The flow passage is formed by a curved The base member 1101 may be formed as a tortuous path, while the base member 1101 may be formed as a It is shaped and formed to rest on the limb.

[0083] A portion of the isolation chamber 1108 is adapted to function as a blood isolation indicator 1109. , from the base member or attached to the top surface of the base member just before exiting the air permeable blood barrier 1110. The indicator 1109 may be made of a transparent material or a material that is in contact with blood. and can be formed of color changing materials.

[0084] In some implementations, the blood isolation device 1100 may include a permanently closed needle, a vacutainer (registered trademark). The blood collection device 1120 may include a blood collection device such as a (Registered Trademark) shield or other collection device. The blood collection device 1120 is manufactured together with the blood isolation device 1100 for efficiency and convenience. can be manufactured and sold, thereby risking contamination from the patient needle insertion process. Therefore, the blood collection device 1120 can isolate the first aliquot of blood. to obtain uncontaminated blood samples to reduce the risk of false positive tests and to It can be done with certainty.

[0085] 12A-12D show a blood sample optimization system 12 according to yet another alternative implementation. 00. The system 1200 may be configured to accommodate a Vacutainer® or other collection and sampling device. A blood isolation device 120 for attachment to a blood collection device 1204, such as a blood collection device. 2. The blood isolation device 1202 includes a Vacutainer® container or vial. The first aliquot or amount of blood is received before being attached to the collection needle of the blood collection device 1204. and isolating the first aliquot or amount within an isolated flow path of the blood isolation device 1202. The device is constructed and arranged to space the

[0086] In some implementations, the blood isolation device 1202 includes an inlet port 1212 and a primary outlet port 1214. and an isolated flow path port. The inlet port 1212 may be connected to a patient needle or associated The main outlet port 1214 can be connected to a vacuum blood collection container or a vacuum tube. Other collection devices such as Tenor®, associated tubing, Luer connectors, syringes Connect to a needle or device that is normally closed to allow connection to a device, luer-actuated valve, etc. The isolation flow passage port can be connected from the main outlet port to the isolation chamber 1218. Separate.

[0087] In some implementations, the isolation chamber 1218 serves as a flow path within the body of the isolation device 1202. The isolation chamber 1218 may be formed as a U-shaped channel, an S-shaped channel, a spiral channel, or any other suitable channel. The flow path may be a tortuous path such as any other tortuous path of the isolating device. 1202 includes a housing or other containment body and one or more flow channels formed therein. As shown in FIGS. 12A and 12B, the isolation device 1202 can be disposed in the body 120. 6 and a cap 1208. The body 1206 has one or more cavities or channels formed therein. The cavity or channel further defines one or more arms 1210 extending from the cap 1208. The one or more arms 1210 are disposed adjacent to a cavity or flow channel in the body 1206. The casing defines a main outlet port and a main exit port.

[0088] 13A-13D show a blood sample optimization system 13 according to yet another alternative implementation. 00. The system 1300 includes a blood collection device 130, such as a Vacutainer®. 4 or other body fluid collection and sampling devices for attachment to blood isolation devices 13 02. The blood isolation device 1302 includes a Vacutainer® container or vial. The first aliquot or amount of blood is taken before being attached to the collection needle of the blood collection device 1304. Receive and transfer the initial aliquot or amount of blood or other body fluid to the blood isolation device 13. The fluid is constructed and arranged to be isolated within the isolation flow path of 02.

[0089] The blood isolation device 1302 includes an inlet port 1314, a primary outlet port 1312, and an isolation The housing 1301 includes an inlet port 1314 and a fluid path port 1316. The main outlet port 1312 can be connected to a needle or associated tubing. Containers or other collection devices such as Vacutainers® and associated tubes and luers A needle or catheter that is normally closed to allow connection to connectors, syringes, luer-activated valves, etc. The isolated flow channel port 1316 can be connected to the main inlet port 131 4 into isolation chamber 1318.

[0090] In the implementation shown in FIGS. 13A-13D, the isolation chamber 1318 is located within the housing 1301. 1301 is formed as a cavity or chamber or is formed by walls that define the housing 1301 The isolation chamber 1318 may be formed in a meandering shape, such as a U-shaped channel, an S-shaped channel, or a spiral channel. A flow path defined by the cooperation and connection of the housing 1301 and the cap 1307. The cap 1307 may be any other tortuous flow path that can be used to separate the isolation chamber. A protrusion that provides one or more walls or directors for the tortuous flow path within the bath 1318. The protrusion 1305 from the cap 1307 may be straight. The protrusion 1305 may be curved or have various channels, openings or recesses embedded therein. The cap 1307 may have grooves and may extend at any angle or orientation from the cap 1307. A cap 1307 is then attached to the housing 1301 to complete the formation of the isolation chamber 1318. When coupled with the protrusions 1305, the protrusions 1305 form at least a portion of a tortuous flow path and isolate The first aliquot is introduced into an isolation channel formed by a serpentine channel within chamber 1318. Isolate any quantity or amounts of blood or other body fluids.

[0091] The isolation chamber 1318 includes an air-permeable blood barrier 1310 substantially as described above. The air in the isolation chamber 1318 is supplied to the isolation chamber 1318 by the patient's blood pressure. The blood is forced through the air permeable blood barrier 1310 by the first aliquot of blood to be The isolation chamber 1318 is filled and the air in the isolation chamber 1318 is expelled. and blood sampling devices such as Vacutainer®. Such a vacuum or other pressure force is used to withdraw the next aliquot or amount of blood or body fluid. The patient's blood pressure is maintained through the blood isolation device 1302, and in particular through the outlet port 131. 2. Further blood draws can be performed with the first aliquot of blood, and any contaminants will be separated. Being isolated within the isolation chamber 1318, these samples will not become contaminated.

[0092] 14A to 14E show blood cultures or tests performed on a patient's blood sample. A blood collection system that isolates contaminants from the first aliquot or sample to reduce false positives. 1 illustrates yet another implementation of the blood sampling system 1400. The blood sampling system 1400 includes a blood sample collection device. A blood isolation device 1403 can be connected between the patient needle (not shown). 401. The blood sample collection device 1403 is a Vacutainer® or the like. The blood isolation device 1401 can be used to access and sample blood. The inlet port can be connected to a patient needle that is inserted into the patient's vascular system for collection of a sample. The inlet port 1402 also includes a tube or other suitable port that may be connected to a patient needle. It can also be connected to a conduit.

[0093] The inlet port 1402 defines an opening to the blood isolation device 1401, the opening being The patient needle should be of the same cross-sectional dimensions as the tubing or other conduit to which it is connected, or the patient needle itself. For example, the opening may have a diameter of about 0.045 inches (1.143 mm). It can be circular, but can be less than 0.01 inches (0.254 mm) to 0.2 inches ( The blood isolation device 1401 may have a diameter of 5.08 mm or more. An outlet defining an opening from the separation device 1401 and into the blood sample collection device 1403. The blood isolation device 140 further includes an inlet port 1404. The outlet port 1404 is similarly 3. The outlet port 1404 may be connected to a tube or other conduit that is connected to the Threaded for mounting various devices including but not limited to tubing, etc. Caps, Luer connectors (male or female), unthreaded interference or glue joints The connector device may further include a connector device such as:

[0094] The blood isolation device 1401 has a sanitary catheter between an inlet port 1402 and an outlet port 1404. The sampling channel 1406 further includes a sampling channel 1406 for the first aliquot. Once the blood is isolated, it functions as a blood sample path. The sump may be a channel or conduit of any size, shape, or configuration. The ring channel 1406 has a cross-sectional area substantially similar to the opening of the inlet port 1402 . In another implementation, the sampling flow path 1406 extends from the inlet port 1402 to the outlet port 140 It can be expanded gradually to 4.

[0095] The blood isolation device 1401 further includes an isolation chamber 1408. 8 is a sampling flow channel at any position between the inlet port 1402 and the outlet port 1404. 1406 and separated or redirected from the sampling flow path 1406, but is preferred. or connected to and proximal to the proximal end of the sampling channel 1406 near the inlet port 1402. The isolation chamber 1408 is initially maintained at atmospheric pressure. The distal end of the isolation chamber 1408 opposite the redirection point from the sampling channel 1406 The air permeable blood barrier 14 includes an air outlet 1412 adjacent thereto. 12. As shown in FIG. 14B, the air permeable blood barrier 1412 is disposed within the protective cover 14 16. The protective cover 1416 is isolated by the patient's own blood pressure. Air is expelled from the isolation chamber by forcing blood into chamber 1408. still allowing air to exit the air permeable blood barrier 1412 when pumped out While the user touches the air permeable blood barrier 1412 with their finger or other external instrument, The protective cover 141 may be dimensioned and configured to prevent the protective cover 141 from being damaged. 6 inhibits or prevents accidental exposure of the air permeable blood barrier to surrounding fluids or splashes This can include adding a hydrophobic membrane to the protective cover. This can be accomplished by a variety of mechanical methods, including but not limited to:

[0096] As shown in FIGS. 14C and 14D, the sampling channel 1406 is a septum that can lyse red blood cells. Cylindrical or conical shapes going from smaller diameter to larger diameter to minimize the possibility of Similarly, the sampling channel 1406 may have a trapezoidal shape. The sampling flow path 14 is formed with a minimal amount or no sharp turns or sharp angles that may cause a problem. 06 through a bypass path 1409 to an isolation chamber 1408 near the inlet port 1402 The bypass path 1409 may have any cross-sectional shape or size, but Preferably, it is similar in cross-sectional shape to at least a portion of the inlet port 1402 .

[0097] In some implementations, the sampling channel 1406 and the isolation chamber 1408 are provided in a housing. 1414 is formed by a groove, channel, lock, or other path formed in the housing 1 414 can be made of plastic, metal or other rigid or semi-rigid materials. The housing 1414 can have a lower member that sealably mates with an upper member. One or both of the lower and upper members may include a sampling channel 1406 and a segregation chamber 1408. 1408, as well as a bypass path 1409, an inlet port 1402, and an outlet port 1404. In some other implementations, the bypass path 1409, the inlet port 1402, and / or One or more of the outlet ports 1404 are connected to either end of the housing 1414. In some implementations, the cap member may be at least partially formed by a cap member that is attached to the cap member. The upper and lower members and the cap member are laser-welded, heat-sealed, adhesively bonded, They can be connected to each other by snap fastening, screw fastening, bolt fastening, etc. In implementations, some or all of the interior surfaces of the bypass path 1409 and / or the isolation chamber 1408 may be It can be coated or filled with agents or substances such as decontaminating agents, coagulants, etc. For example, the isolation chamber 1408 may be filled and the first aliquot of blood may be diverted to the bypass path 1409. Upon return, the last amount of isolated blood clots and enters the isolation chamber 1408 and the sampling flow channel. A coagulant can be provided to the bypass path 1409 to create a barrier between the bypass path 1409 and the path 1406. can.

[0098] 15A-15G show a blood isolation device 1500. The blood isolation device 1500 is , other collection devices such as evacuated blood collection containers or Vacutainers®, and associated tubes Normally closed to allow connection to a luer connector, syringe, luer-actuated valve, etc. The catheter may be connected to a needle or device that is

[0099] The blood isolation device 1500 is a device for accessing and withdrawing a blood sample. 15. The catheter includes an inlet port 1502 that can be connected to a patient needle that is inserted into the patient's vascular system for The inlet port 1502 is connected to a tube or other conduit which in turn is connected to a patient needle. The inlet port 1502 defines an opening to the blood isolation device 1500. This opening is of the same diameter as the tubing or other conduit that is connected to the patient needle, or the patient needle itself. For example, the opening may be approximately 0.045 inches (1.143 mm) The diameter of the conductor may be 0.01 inches (0.254 mm) or less. It may have a diameter of 0.2 inches (5.08 mm) or greater.

[0100] The inlet port 1502 may also be fitted with a sealing or other fitting, such as a threaded or luer fitting. In some implementations, the catheter may include a fluid-tight connector or connection that is coupled to a patient needle. The tubing or other conduits used may be co-molded, glued, laser welded, or thermally bonded between the components. The inlet port 1502 can be integrated with the inlet port 1502 by, for example, The device 1500 is manufactured and sold as a single unit with a patient needle to draw blood or perform a sample. This eliminates the need to connect the patient needle to the blood isolation device 1500 during blood pulling. do.

[0101] The blood isolation device 1500 is connected to a blood sampling device 1500. The outlet port 1504 further includes an outlet port 1504 that defines an opening to the vise. It may also be connected to tubing or other conduits that are connected to a blood isolation device. Includes hermetic or fluid-tight connectors or connections such as threaded or luer fittings. Thus, as described above, the blood isolation device 1500 can be used to Manufactured and sold as a single unit with the tube and blood sample collection device, When sampling blood, the patient needle and blood sample collection device are connected to the blood isolation device 15 This eliminates the need to connect to 00.

[0102] The blood isolation device 1500 includes a sink between an inlet port 1502 and an outlet port 1504. The sampling channel 1506 further includes a sampling channel 1506 for the first aliquot. Once the blood is isolated, it functions as a blood sample path. The channel or conduit may be of any size, shape, or configuration. The pulling channel 1506 has a cross-sectional area substantially similar to the opening of the inlet port 1502. In another implementation, the sampling flow path 1506 extends from the inlet port 1502 to the outlet port 1506. It can gradually expand to 04.

[0103] The blood isolation device 1500 further includes an isolation chamber 1508. 8 is a sampling flow channel at any position between the inlet port 1502 and the outlet port 1504. 1506 and separated or redirected from the sampling flow path 1506, but is preferred. or connected to and proximal to the proximal end of the sampling channel 1506 near the inlet port 1502. In some implementations, the detour includes a Y-junction. The chamber 1508 is preferably maintained at atmospheric pressure, and the distal end of the isolation chamber 1508 or The vent 1510 includes an air permeable blood barrier 1512. FIG. 15C shows the isolation chamber 1508 receiving the first aliquot or sample of blood from the patient. 15 shows the blood isolation device 1500 filled with blood.

[0104] The air permeable blood barrier 1512 can be covered with a protective cover 1516 . The protective cover 1516 prevents blood from being forced into the isolation chamber 1508 by the patient's own blood pressure. When air is expelled from the isolation chamber by supplying air, the air becomes air permeable. While still allowing blood to exit the blood barrier 1512, the user may It is sized to prevent contact with the air permeable blood barrier 1512 by other external instruments. The protective cover 1516 may be configured to protect the filter from accidental exposure to surrounding fluids or splashes. This can be achieved by using protective covers to prevent or prevent accidental exposure to the This can be accomplished by a variety of mechanical methods, including but not limited to adding a hydrophobic membrane to the can be done.

[0105] FIG. 15B illustrates a blood isolation device 1500 including an outlet port 1504 and a vent 1510. FIG. 15 is a perspective view of a blood isolation device 1500 from the top of a housing 1501 including a sample Before the collection device is activated, the first aliquot is taken while the sampling channel 1506 is empty. FIG. 15G shows the blood of the patient filling the isolation chamber 1508. 500 outlet port 1504 and the blood isolation device 15 from the bottom of the housing 1501 15 is a perspective view of the sampling channel 1506 before the sample collection device is activated. 15 shows a first aliquot of blood filling the isolation chamber 1508 while the blood is empty. 15C is a diagram of a blood isolation device 1500 including an inlet port 1502 and a vent 1510. FIG. 15 is another perspective view of the blood isolation device 1500 from the top of the housing 1501. The blood is then passed through the sampling flow path while the blood remains substantially within the isolation chamber 1508. This indicates that the signal is collected through 1506.

[0106] FIG. 15D is a cross-sectional view of a blood isolation device 1500 according to some implementations. 15 shows a housing 1501 defining a pumping channel 1506 and a segregation chamber 1508. 15E and 15F are housings for blood isolation devices according to one or more implementations described herein. 1 shows various form factors for the 3G network.

[0107] The isolation chamber 1508 has a larger cross-sectional area than the sampling channel 1506. The cross-sectional area or length can be configured to isolate or lock in a predetermined or specific volume of blood. The sampling channel 1506 can be a tube of a patient needle or a blood collection device. may be sized to fit either or both of the tubes. can.

[0108] The housing 1501 can be formed from multiple pieces or a single unitary piece. In some implementations, as shown in FIG. 15D, the housing 1501 may include mating upper portions. The molded article includes a top member 1520 and a bottom member 1522, one or both of which may be formed, for example, by injection molding. Grooves, channels, locks, etc., that are preformed by the process or by etching, cutting, drilling, etc. The upper member 1520 may be laser welded, thermally bonded, ultrasonically welded, or otherwise secured to the upper member 1520. Any fitting or connection mechanism, such as by bonding, gluing, screws, rivets, bolts, etc. or by other mating features such as latches, grooves, tongues, pins, flanges, etc. It can be connected to material 1522.

[0109] In some implementations, such as that shown in FIG. 15D, the upper member 1520 may include grooves, channels, locks, conduits, etc. or other passages, while the lower member 1522 may include grooves, flow channels, or other passages in the upper member 1520. Dimensioned and adapted to fit into at least one of a passage, a lock, or other passage The protrusion 1524 may include a protruding portion 1524 that is formed on the sample flow path. To complete the formation of either the passage 1506 and / or the isolation chamber 1508, a portion In some implementations, surface features such as protruding grooves or partial channels may be provided. Portion 1524 is adapted to fit more snugly within a corresponding groove, channel, lock, or other passageway. In yet another embodiment, the upper surface of the slab may be formed with one or more sloping sides or faces. Both the upper member 1520 and the lower member may have grooves, channels, locks or other passages, as well as one or more It may include a protrusion 1524 .

[0110] In some implementations, the sampling channel 1506 and the isolation chamber 1508 are provided in a housing. 1501 is formed by a groove, channel, lock or other path formed in the housing 1 501 may be made of any suitable material, including rubber, plastic, metal, or other materials. The housing 1501 can be made of a transparent or translucent material, or an opaque or In other implementations, the housing 1501 may be formed from a non-translucent material. The sampling channel 1506 and / or The housing surface immediately adjacent the isolation chamber 1508 is transparent or translucent and first A visual cue or indication that the isolation chamber 1508 is filled to the required or desired degree. , and / or a next uncontaminated blood sample is passed through the sampling channel 1506. A visual cue that the isolated blood remains isolated while being collected through the Other visual cues or signs of isolation may be provided to practitioners, including but not limited to: However, contact with, penetration by, or partial penetration of blood may cause the air permeable blood barrier 1512 to become different. at any location along or adjacent to the isolation chamber; may include color-coded tabs or indicators, audible, vibrating, or other signals can.

[0111] The patient is immunized with a needle (not shown) which may collect a large number of pathogens from the patient's skin. After pulse puncture, the patient's own blood pressure overcomes the atmospheric pressure in the isolation chamber 1508, forming an air permeable When the air in the isolation chamber 1508 is expelled through the blood barrier 1512, these An initial volume of the patient's blood carrying the pathogen is introduced into the blood isolation device 1500 at the inlet port 1502. and flows into the isolation chamber 1508 by following the path of least resistance. The patient's blood pressure overcomes the air pressure building up within the sealed sampling channel 1506. Finally, the isolation chamber 1508 having a predetermined volume is air permeable. The blood fills the blood barrier 1512, which expels air. Upon impact with the rear, blood interacts with the material of the air permeable blood barrier 1512 and enters the vent 1510. The practitioner now seals the Vacutainer® cap. A blood sample is then collected from the patient for sampling using a blood cell or other blood sampling device. A signal or indication can be provided that the amount of segregation chamber 1 can be obtained. The blood in 508 is now effectively isolated within the isolation chamber.

[0112] After filling the blood isolation pathway 1508, a Vacutainer® or other blood sample Prior to use of the sampling device, the patient's blood pressure is measured by compressing the air in the sampling channel 1506. This may cause a small amount of blood to pass the diversion point into the isolation chamber 1508. The contaminant is then transported to the sampling flow path 1506 and collected through the sampling flow path 1506. Queue unstained blood.

[0113] In some cases, as shown in FIG. 15H, the inlet port 1532 may be a removable patient The outlet port 11534 may include a male luer connector for connecting to a needle. The inlet and outlet ports may include a female Luer connector for connection to a syringe. This implementation of the technique avoids the tendency of Vacutainer type devices to collapse the patient's veins. This implementation can be used with any of the devices described herein to allows clinicians to draw blood samples using a syringe in a coordinated manner. In operation, a syringe is attached to the outlet port 1004 and a needle is attached to the inlet port 1002. Venipuncture is performed with a needle and without the clinician withdrawing a syringe. The first aliquot of blood fills the isolation chamber, and then the syringe is used to fill the isolation chamber. The blood sample can be taken through the collection channel, bypassing the blood isolated in the chamber. can.

[0114] 16-19 show yet another implementation of a blood isolation device. A blood sample collection device, such as an evacuated blood collection container like the Cyutainer® (not shown) and a patient needle (not shown) and / or associated tubing. FIG. 17 shows the lower part of the blood isolation device 1600. 8 shows the upper member of the blood isolation device, the upper and lower members being described in more detail below. As described, the inlet port, the outlet port, the isolation chamber and the sampling chamber are interfitted. 19A and 19B show a top member and a bottom member that fit together to form a groove. 16-19 show one of the components of the blood isolation device described herein. It should be understood that an exemplary method is shown and other configurations are possible.

[0115] 16A-16D, a blood isolation device 1600 provides access to a blood sample. and connect to a patient needle that is inserted into the patient's vascular system for access and collection of blood samples. The inlet port 1602 also connects to a patient needle. The inlet port 1602 may be connected to a tube or other conduit. The device defines an opening to the chair 1600, which may be used to connect a tube or It can be of the same cross-sectional dimensions as the other conduits or the patient needle itself. For example, the opening can be approximately 0. The diameter of the hole may be 0.01 in. (1.143 mm) or less. The diameter must be less than 0.254 mm and greater than 0.2 inches (5.08 mm). can be done.

[0116] The inlet port 1602 may also be fitted with a sealing or other fitting, such as a threaded or luer fitting. In some implementations, the catheter may include a fluid-tight connector or connection that is coupled to a patient needle. The tubing or other conduits used may be co-molded, glued, laser welded, or thermally bonded to the components. This allows the blood isolation device to be integrated with the inlet port 1602. The Vise 1600 is manufactured and sold as a single unit with the patient needle and / or tubing. This eliminates the need to connect a patient needle to the blood isolation device 1600 during blood collection or sampling. It can be eliminated.

[0117] The blood isolation device 1600 is connected to a blood sampling device 1610. The outlet port 1604 further includes an outlet port 1604 that defines an opening to the vise. It may also be connected to tubing or other conduits that are connected to a blood isolation device. Includes hermetic or fluid-tight connectors or connections such as threaded or luer fittings. Thus, as described above, the blood isolation device 1600 may be connected to a patient needle and / or Manufactured and sold as a single unit with the tube and blood sample collection device, When sampling blood, the patient needle and the blood sample collection device are connected to the blood isolation device 16 This eliminates the need to connect to 00.

[0118] The blood isolation device 1600 includes a septum between an inlet port 1602 and an outlet port 1604. The pulling channel 1606 and any position between the inlet port 1602 and the outlet port 1604 and a sampling flow path 1606 is connected to the sampling flow path 1606 and separated or directed from the sampling flow path 1606. The sampling channel 1606 further includes a separation chamber 1608 that is converted into a Once the first aliquot of blood has been isolated within the isolation chamber 1608, it functions as a blood collection channel. The sampling channel 1606 may be a channel or conduit of any size, shape, or configuration. In some implementations, the sampling channel 1606 can be In another implementation, the sampling channel 1606 has a cross-sectional area substantially similar to that of the opening. The isolation chamber can gradually expand from the inlet port 1602 to the outlet port 1604. The blood is then passed through the sampling channel 1608, as shown in more detail in FIGS. 6, whereas the smaller diameter of the isolation channel tries to enter the reservoir first. The passageway may have a larger cross section to form a larger reservoir.

[0119] In some exemplary implementations, between the sampling channel 1606 and the isolation chamber 1608 The change in direction is due to the diverter bifurcation point 1607. The diverter bifurcation point 1607 is In some preferred exemplary embodiments, the shape of the slit 14 may be substantially Y-shaped, T-shaped, or U-shaped. In this embodiment, as shown in FIGS. 17A-17B, the diverter branch point 1607 is connected to the inlet port 16 02 is preferentially directed to the isolation chamber 1608. The chamber 1608 directs the initial blood flow toward the isolation chamber 1608 and into the isolation chamber 160 8. The device may also include or form a curve or ramp for directing the device into the 8.

[0120] The isolation chamber 1608 is preferably maintained at atmospheric pressure, and the distal portion of the isolation chamber 1608 The vent 1610 may be used to vent the air permeable blood vessel 1600 as described above. A liquid barrier 1612 may be included.

[0121] The blood isolation device 1600 can be formed from multiple pieces or a single, integral piece. In some implementations, the housing 1601 may include a housing 1602 that may be used to mount the device. As shown in 18A-18F, the housing 1601 includes a mating upper member 1620. and a lower member 1622. The blood isolation device 1600 includes an upper member 1620 and a lower member 1622. When the material 1622 is mechanically attached to the substrate 1622, the interface between the two forms a gasket or seal. A gasket or other sealing member (not shown) may be included to provide a seal with the member. 17A-17E show a lower member 16 of a housing for a blood isolation device 1600. 22. The lower member 1622 includes the sampling channel 1606, the isolation chamber 1608, and by injection molding process or etching to form diverter branch point 1607. Preformed grooves, channels, locks, conductors, etc. in the lower member 1622 by drilling, cutting, drilling, etc. It may include a tube or other passageway.

[0122] The isolation chamber 1608 prevents blood from entering the smaller diameter of the sampling channel 1606. In contrast, the sampling channel 1606 is arranged so that the particles move preferentially into the isolation chamber first. The cross section may be larger than the cross section of the slit.

[0123] Figures 18A-18F show the use of laser welding, thermal bonding, adhesives, screws, rivets, bolts, etc. By any fitting or connecting mechanism, such as by using a latch, groove, tongue, pin, flip-top, etc. An upper member 1620 that can be connected to a lower member 1622 by other mating mechanisms such as flanges. The upper member 1620 includes the sampling channel 1606, the isolation chamber 1608, and the diaphragm 1609. A groove, channel, lock, conduit or other part of a pathway to form a diverter branch point 1607. In yet another embodiment, the upper member 1620 and the lower member 16 Both of 22 may include grooves, channels, locks, or other pathways.

[0124] In some implementations, the sampling channel 1606 and the isolation chamber 1608 are disposed within a housing. 1601 is formed by a groove, channel, lock or other path formed in the housing 1 601 can be made of rubber, plastic, metal or any other suitable material. The housing 1601 may be made of a transparent or translucent material, or may be opaque or non-translucent. In other implementations, the housing 1601 can be made of a majority of non-ferrous materials. The sampling channel 1606 and / or the isolation channel may be transparent or non-translucent. The housing surface immediately adjacent member 1608 may be transparent or translucent, and initially a visual cue that the isolation chamber 1608 is filled to the required or desired degree. or sign, and / or the next uncontaminated blood sample is passed through the sampling channel 160 A visual cue or indication that the isolated blood remains isolated while it is being collected through 6 Other visual cues or signs of isolation may include but are not limited to: However, the air permeable blood barrier 1612 may be contacted, penetrated, or partially penetrated by blood. Change to a different color anywhere along or adjacent to the isolation chamber. Including some color-coded tab or indicator, audible signal, vibrating signal, or other signal can be done.

[0125] As shown in FIGS. 18A-18F, the air permeable blood barrier 1612 includes a protective member 1616 The protective member 1616 may be covered with or surrounded by a protective member. 1616 is an air permeable blood filter that is used to pump air out of the isolation chamber 1608. While still allowing the user to exit the barrier 1612, they can use their fingers or other Dimensioned and configured to prevent contact of the air permeable blood barrier 1612 with external instruments. In some implementations, the protective member 1616 can be formed on the upper surface of the top member 1620. The protective member 1616 includes a protrusion extending from the air permeable blood barrier 1612 upwardly around the air permeable blood barrier 1612. is configured to inhibit or prevent accidental exposure of the filter to ambient fluids or splashes This can include, but is not limited to, adding a hydrophobic membrane to the protective cover. This can be done in a variety of mechanical ways, without the need for a separate process.

[0126] In use, the blood isolation device 1600 includes a sampling channel 1606 and an isolation chamber 1608. 08. Both paths are initially filled with air at atmospheric pressure, but the sampling path 1606 is a Vacutainer® or other such sealed blood collection device. The air is directed to the outlet port 1604, which is initially sealed, and the isolation chamber 1608 is emptied. It terminates in a vent 1610 to the atmosphere that contains an air-permeable blood barrier 1612 .

[0127] Venipuncture with a patient needle (not shown) that may collect a large number of pathogens from the patient's skin After this, the first volume of the patient's blood carrying these pathogens is introduced into the blood isolation device 1600. This initial volume of potentially contaminated blood passes through the oral port 1602. By finding the path of least resistance, it will preferentially flow into the isolation chamber 1608. The subject's own blood pressure overcomes the atmospheric pressure in the vented isolation chamber 1608, which is air permeable Air in the isolation chamber 1608 is expelled through the blood barrier 1612, but the sealed chamber In various examples, the air pressure is insufficient to overcome the air pressure building up in the sampling channel 1606. In the illustrated embodiment, the isolation chamber 1608 and sampling channel 1606 are The force generated by the pressure overcomes the effects of gravity, regardless of the orientation of the blood isolation device. It can be configured to be sufficient.

[0128] Finally, the isolation chamber 1608 is adapted to allow air to pass through the air permeable blood barrier 1612. Once the blood comes into contact with the air-permeable blood barrier, the blood 16. The vent 1610 may be fully or partially formed by interacting with the material of the air-permeable blood barrier 1612. Practitioners now have access to Vacutainers or other blood collection devices. A signal or indication may be provided that the device is capable of detecting the presence or absence of a signal.

[0129] After filling the blood isolation channel 1608, a Vacutainer® or other blood sample Prior to use of the sampling device, the patient's blood pressure is measured by compressing the air in the sampling channel 1606. This can cause a small amount of blood to pass the diversion point and enter the sampling channel 160 6 and wait for uncontaminated blood to be collected through sampling channel 1606. Put in queue.

[0130] FIG. 19A is a side view of blood isolation device 1600, and FIG. 19B is a side view of the blood isolation device. 16 is a cross-sectional view of a gas 1600 showing an upper member 1620 mating with a lower member 1622.

[0131] FIG. 20 illustrates a patient needle 2002 for vascular access to a patient's bloodstream and one or more blood samples. a blood sample collection device 2004 for facilitating collection of a blood sample; and a conduit 2006 that provides a fluid connection between the blood sampling device 2004 and the sample collection device 2004. 2 illustrates a sample optimization system 2000. In some implementations, the blood sample collection device 20 04 is a protective shield containing a sealed sampling needle on which a sealed vacuum vessel is placed Once pierced by the collection needle, the vacuum vessel is connected to the patient needle 2002 via the conduit 2004. The blood sample is drawn through 06 using vacuum pressure or force.

[0132] The blood sample optimization system 2000, as described herein, includes a patient needle 2002 and the blood sample collection device 2004 at any point on the conduit 2006. It further includes an isolation device 2008 .

[0133] FIG. 21 illustrates a non-vented blood isolation device 2 using a wicking material chamber. 100. The blood isolation device 2100 includes an isolation chamber filled with a wicking material. A sampling channel 2104 that is at least partially surrounded or adjacent by the bath 2102. The housing 2101 includes a first aliquot of blood sampled from a patient needle. The sample is drawn into the flow path 2104, and the sample is drawn into the flow path 2104 of the isolation chamber 2102. The air is immediately wicked away into the wicking material. 102 is a sampling flow path through which subsequent or subsequent blood draws pass the wicking material. 2104 directly into a sampling device such as a Vacutainer®. The blood vessel is sized and adapted to receive and hold a predetermined volume of blood. The sticking material may include substances such as solidifying agents, decontaminating agents, or other additives. .

[0134] As described herein, air permeable blood barriers can be made in a wide variety of different structures and materials. As shown in Figures 22A and 22B, the blood isolation device can be made of The air permeable blood barrier 2202 of 2200 is adapted to render at least some of the beads hydrophilic. The polymeric bead matrix 2204 may be treated as follows: The liquid barrier 2202 is made of a material such as carboxymethyl cellulose (CMC) or cellulose gum. The blood barrier 2202 may further include a self-sealing material 2206, or other sealing material. The nozzle has a gap 2208 that allows air flow before or during partial contact with a fluid such as blood. As shown in FIG. 22B, upon contact with a fluid, a self-sealing material 22 06 expands and closes off the gap 2208, blocking air flow through the gap 2208 and completely Or partially sealed.

[0135] 23A and 23B show an inlet port 2302 for connecting to a patient needle and a blood sample An outlet port 2304 for connecting to a collection device, an isolation chamber 2306, and an isolation The isolation chamber is filled until the first aliquot of potentially contaminated blood is and a sampling flow path 2308 that bypasses the isolation chamber 2306. 23 shows yet another implementation of device 2300. Isolation chamber 2306 is connected to inlet port 23. The distal end of the isolation chamber 2306 furthest from the vacuum chamber 2302 includes a hydrophobic plug 2312. A vacuum force or other force applied from an exit port 2304, such as from a Tenor® The suction force of the blood draws blood into the inlet port 2302 and directly into the isolation chamber 2306. where the first aliquot of blood contacts the hydrophobic plug 2312, The blood is returned to the isolation chamber 2306 and isolated there. However, the gas can enter the sampling channel 2308, which is initially closed by the valve 2308. When the valve 2308 is released, a subsequent volume of blood can be drawn under the further force of the vacuum or other force. The flow enters the inlet port 2302, bypasses the isolation chamber 2306, and passes through the sampling channel 2308. 2304 to be delivered to a collection device.

[0136] The sampling channel 2308 can have any suitable geometric shape, plus The valve 2308 may be formed from tubing or any other suitable material. Before the first aliquot of blood is isolated in the isolation chamber 2306, the sampling flow path With a clip or other containment device to pinch, deflect, bend, or otherwise close For example, the valve 2308 can be a flap, a drop, or the like in the sampling channel 2308. Alternatively, the device may be formed as a window or a barrier that can be closed.

[0137] 23C-23E show an alternative implementation of a blood isolation device 2300', In the isolation device 2300', the isolation chamber 2320 includes an inlet for connecting to a patient needle. Oral port 2316 and a blood sample collection device such as a Vacutainer® or syringe The separation channel 2322 branches off from the main collection channel 2322 between an outlet port 2318 that connects to the separation channel 2322. Member 2320 may be, for example, a hydrophobic plug of material or a filter formed of one or more layers. The blood barrier 2324 is air permeable and blood impermeable. 322 can be opened and closed and device 2300' can be used in the same manner as described above.

[0138] 24A-24D show a patient needle 2402 for vascular access to a patient's bloodstream and a blood test needle 2404 for blood sampling. A blood sample collection device that facilitates the collection of one or more blood samples for blood screening or blood culture. The fluid connection between the patient needle 2402 and the blood sample collection device 2404 is 24. The blood sample optimization system 2400 includes a conduit 2406 providing a connection between the In implementation, the blood sample collection device 2404 has a sealed evacuated container disposed thereon. the vacuum vessel includes a protective shield containing a sealed sampling needle, the vacuum vessel being sealed once pierced by the sampling needle; Once punctured, the blood sample is drawn by vacuum pressure or force from the patient needle 2402 through the conduit 2006. Inhale the oil.

[0139] The blood sample optimization system 2400 includes a patient needle 2402 and a blood sample collection device. 2404. A blood isolation device 2408 located at any point on the conduit 2406 between the The location of the blood isolation device 2408 is determined by the distance between the blood isolation device 2408 and the patient needle 240. The length of the conduit between the two and the associated volume that that length provides can be used to determine the desired volume.

[0140] A blood isolation device 2408 faces the patient needle 2402 and is connected to the conduit 2406. An inlet port 2412 and a conduit 2406 facing the blood sample collection device 2404. The housing 2416 includes an outlet port 2414 connected thereto. 24A-24D as being substantially cylindrical, it may be of any shape. 2416. Although shown to be located at either end of the housing 2416, It includes an inlet port 2412 and an outlet port 2414 that can be located anywhere.

[0141] The blood isolation device 2408 includes a blood isolation chamber 24 connected to an inlet port 2412. The blood isolation chamber 2418 is enclosed by an inner chamber housing 2419. The inner chamber housing 2419 is defined by a first aliquot of blood. From the first position where the blood is isolated by the inner chamber housing 2419, the blood flows around the inner chamber housing 2419 to the inner chamber. The housing 2419 is defined by an outer surface thereof and an inner surface thereof. To allow bypass and / or flow through the blood sample flow path 2422, A second aperture 2424 exposing one or more openings 2424 at the proximal end of the chamber housing 2419. The blood isolation chamber 2418 can be moved to a position of It includes an air permeable blood barrier 2420 at its distal end.

[0142] During operation, one or more openings 2424 are closed to prevent blood from entering the blood isolation chamber 2418 from the patient needle. In a direct path from the inlet port 2412, the inner chamber housing 2419 In this first position, the patient is punctured by venipuncture and the syringe or Vacutainer® is inserted. or other blood collection device 2404, the first aliquot of blood is placed in the blood isolation chamber. Once the first aliquot of blood has flowed into the blood isolation chamber, The blood displaces the air in the blood isolation chamber, and eventually the blood penetrates the blood barrier 2420. 2. The inner chamber housing 24 contacts the inner chamber housing 24 and urges it into the second position. 19 and / or housing 2416, the blood isolation chamber 2418 is filled and the locking mechanism 2419 to the second position. One or more actuators may be provided to maintain the inner chamber housing 2419 in the first position until the actuator is ready to operate. This may include a locking mechanism such as a small tab, groove, detent, ridge, or ridge on the top. Once in the second position, the first aliquot of blood is isolated in the blood isolation chamber 2418. and one or more openings 2424 are opened to bypass the blood isolation chamber 2418 and and / or a blood draw flow path 242 from the inlet port 2412 flowing around the blood isolation chamber 2418 This creates a route to 2.

[0143] As described above, the housing 2416 and / or the inner chamber housing 2419 may be circular. It can be formed as a cylinder and concentric circles, but can also be square, rectangular, elliptical, oval, or The inner chamber housing 2419 can be of any shape, including other cross-sectional shapes. The outer surface of the distal end of the proximal end of the proximal end of the proximal end of the distal ... proximal end The tongue 2421 can be attached to the inner surface of the housing 2416. 2422 between them and the inner chamber housing. The gap between the tongues 2421 helps to stop the tongue 2419 in the second position. Allows blood to flow through blood collection channel 2422 to outlet port 2414. The housing 2419 is in a second position and the blood isolation chamber 2418 is configured to receive a first aliquot of blood. When the coat is full, an additional blood sample is admitted through the inlet port 2412 Through one or more openings 2424, through the blood collection flow path, through the gap between the tongues 2421, and finally flows automatically through the outlet port 2414 and is then drawn by the blood collection device 2404. Can be collected.

[0144] 25A-25D are shaped substantially as shown in FIGS. However, if a user or other object touches the mechanism for removing air from the blood isolation chamber 2520, 4. The blood optimization system 2500, configured to prevent the blood from being blocked by the blood supply or the air vent mechanism. and blood isolation device 2502. Initially, air in the blood isolation chamber 2520 is The first access during venipuncture is when the patient's blood pressure overcomes the ambient air pressure in the blood isolation chamber 2520. The air vent mechanism allows air to escape. A porous material or set of materials that prevents blood from exiting the blood isolation chamber 2520. Which includes an air permeable blood barrier 2506.

[0145] The air venting mechanism at least partially surrounds or surrounds the air permeable blood barrier 2506. The outer wall 2504 includes a surrounding inner wall 2516 and an outer wall 2504 spaced apart from the inner wall 2516. , the outer wall 2504 may have one or more air holes 2514 formed therein. 504 attaches a lid 2510, such as a cap, plug, cover, etc., to the outer wall 2504. , so that it can be moved a small distance from the top of the inner wall 2516. 6. The silicon in the form of a silicon wafer or other elastomeric material. A seal 2508 fits within the outer wall 2504 to cover the air permeable blood barrier 2506 and an inner wall 2516. The seal 2508 covers the air permeable blood barrier 2506. It is sealed and air passes through the air permeable blood barrier 2506 into the blood isolation chamber 2520 The fulcrum 2512 on the underside of the lid 2510 prevents the seal 2508 from reaching the blood isolation chamber. When pushed by the air exhaled from 2520, the inner wall 2516 is flexible and extends outward. 2504 , allowing air to permeate through one or more air holes 2514 in the exterior wall 2504 . This allows the blood to exit the vascular blood barrier 2506.

[0146] 26A-26E show a patient needle 2602 for vascular access to a patient's bloodstream and a blood test needle 2604 for blood sampling. A blood sample collection device that facilitates the collection of one or more blood samples for blood screening or blood culture. The fluid connection between the patient needle 2602 and the blood sample collection device 2604 is 26 shows a blood sample optimization system 2600 including a conduit 2606 providing a connection to the 606 may include a flexible tube. In a preferred embodiment, the blood sample collection device The seat 2604 includes a protective device including a sealed sampling needle on which a sealed vacuum vessel is placed. The vacuum vessel includes a shield 2605, which, once pierced by the collection needle, is protected from the patient needle 26 02 through conduit 2006 using vacuum pressure or force to draw a blood sample.

[0147] The blood sample optimization system 2600 includes a patient needle 2602 and a blood sample collection device. 2604. A blood isolation device 2608 located at any point on the conduit 2606 between the The location of the blood isolation device 2608 is determined by the distance between the blood isolation device 2608 and the patient needle 260 The length of the conduit between the two and the associated volume that that length provides can be used to determine the desired volume.

[0148] A blood isolation device 2608 faces the patient needle 2602 and is connected to the conduit 2606. An inlet port 2612 and a conduit 2606 facing the blood sample collection device 2604. The blood isolation device 2608 includes a cylindrical and the outer housing 2616 and the inner housing 261 are concentrically connected. The outer housing 2616 includes an outer wall 2618 and an inner wall 2622 that defines a blood collection channel 2622. and a side conduit 2620 to carry blood through the conduit 2606 to the blood collection device 2604. The side housing 2617 is fitted between the inner conduit 2620 and the outer wall 2618 of the outer housing. The outer housing 2616 is a tight fit and is rotatable relative to the outer housing 2616. The fit between the inner housing 2617 and the inner housing 2618 provides a frictional fit that maintains the housing in a particular position. The inner housing 2617 includes a blood isolation chamber 2624, preferably or a spiral or turn around the outer surface of the inner conduit 2620 of the outer housing 2616. 26E, defining a flow passage having an air permeable blood barrier 262. It ends with 8.

[0149] The blood isolation chamber 2624 is configured to receive and store blood from the blood isolation device when the blood isolation device is in a first state, as shown in FIG. When the blood is drawn through the bypass branch point 2624 formed in the inner conduit 2620, 22. A protective shield 2606 on the collection needle 2604 prevents any barrier for air or blood. provides a barrier to blood flow by allowing the patient's blood pressure to overcome the ambient air pressure in the blood isolation channel 2624. When air is expelled from the isolation channel 2624 through the air hole 2628, the first aliquot The blood separator 2626 allows blood in the blood vessel to be directed into the blood isolation chamber 2624.

[0150] As shown in FIG. 26D, the inner housing 2617 is attached to the outer housing 2616. When rotated to the second state, or vice versa, the blood isolation chamber 2624 is connected to the bypass branch point 2 624, and the blood is collected from the patient needle through the conduit 2606 by the blood collection flow path 2622. A direct path to the needle 2604 is provided. The rings 2617 are arranged to facilitate relative rotation from the first state to the second state. It may include ridges or grooves formed in a portion of the surface.

[0151] 27A-27D are substantially similar to at least FIGS. It is configured as described with reference to the blood isolation chamber 272, except that a user or other object 0. A blood vessel configured to prevent contact with or blocking of the air vent mechanism. A fluid optimization system 2700 and a blood isolation device 2702 are shown. The air in the blood isolation chamber 2720 flows in such a way that the patient's blood pressure overcomes the ambient air pressure in the blood isolation chamber 2720. The air vent mechanism is displaced by the first aliquot of blood during venipuncture. Perforations that allow blood to escape but prevent blood from exiting the blood isolation chamber 2720. The blood supply 2702 includes an air permeable blood barrier 2706, such as a porous material or set of materials.

[0152] The air venting mechanism at least partially surrounds or surrounds the air permeable blood barrier 2706. The cap 272 includes a surrounding inner wall 2716 and an outer wall 2704 spaced apart from the inner wall 2716. 2 preferably fits between the inner wall 2716 and the outer wall 2704 of the air vent mechanism, and the inner wall 27 16 or outer wall 2704 or both. The cap 2722 is fitted with a plug 2723 extending downward. One or more vent holes 2724 or 726 extending through the top surface of the cap 2722. The plug 2726 may further include a slit, an opening, a hole, etc. The plug 2726 is defined by an inner wall 2716. The housing is sized and adapted to fit snugly within the space defined therein.

[0153] As shown in FIG. 27C, in the first position, the cap 2722 is positioned over the blood isolation chamber. Air from 2720 passes through the air permeable blood barrier 2706 and through one or more vents 27 24. Once the blood is Once the air from the fluid isolation chamber 2720 has been expelled, i.e., the blood isolation chamber 27 Once the 20 is filled with the first aliquot of potentially contaminated blood from the patient, the cap 2722 is depressed onto the air vent mechanism in the second position as shown in FIG. 27D. 2706, so that the plug 2726 is inserted into the inner wall 2706 on the air permeable blood barrier 2706. 716 and seals the air vent mechanism. However, the cap 2722 protects the air permeable blood barrier 2706 from the atmosphere or from contact by the user. Protect the equipment from unauthorized access.

[0154] 28A-28F are substantially the same as at least FIGS. 26, but with a multi-layer filter and, in some implementations, an air permeable and a filter with trapped reactants for a transient blood barrier. A system 2800 and a blood isolation device 2802 are shown. The air permeable blood barrier 2803 allows air to pass through both layers while preventing blood from entering the A first layer 2804 of an air permeable but blood impermeable material to repel water and a hydrophobic material and a second layer 2806 that includes a reactant such as a vacant The air-permeable blood barrier 2803 is the same air-permeable but blood-impermeable layer as the first layer 2804. Any number of layers may be included, such as a third layer 2808 formed from a material, while a second Layer 2806 contains an entrapped or embedded blood-reactive material.

[0155] 29A-29C are substantially the same as at least FIGS. 26, except that the blood isolation chamber 2904 is formed as described with reference to The blood optimization system 2900 and blood, partially filled with blood absorbing material 2906. An isolation device 2902 is shown. Blood absorbing material 2906 is provided to absorb blood during venipuncture and to prevent blood from entering the patient. Before using a blood collection device such as a Tutener® or syringe, collect the blood to be isolated. It can also act as a wicking material for absorption.

[0156] 30A-30G are substantially the same as at least FIGS. 26, a blood optimization system 3000 and a blood isolation device The blood isolation device 3002 is shown. The blood isolation device 3000 provides access to and collection of a blood sample. The catheter can be connected to a patient needle that is inserted into the patient's vascular system for the withdrawal of a fluid sample. The inlet port 3002 also includes a tube that connects to a patient needle. The inlet port 3002 may be connected to a blood pump or other conduit. 000, which defines an opening for tubing or other conducting material that is connected to the patient needle. The opening can be of the same cross-sectional dimension as the tubing or patient needle itself. For example, the opening can be approximately 0.045 The diameter of the hole may be 0.01 inch (1.143 mm) or less. It can have a diameter of 0.2 inches (5.08 mm) or less to 0.2 inches (0.254 mm) or more. do.

[0157] The inlet port 3002 may also be fitted with a sealing or The catheter may include a fluid-tight connector or connection. In some implementations, the catheter may include a catheter that is coupled to the patient needle. The tube or other conduit may be co-molded, glued, laser welded, or thermally bonded to the components. 3002. This allows the blood isolation device to be The 3000 is manufactured and sold as a single unit with a patient needle and / or tube, Eliminates the need to connect a patient needle to the blood isolation device 3000 when sampling blood It is possible.

[0158] The blood isolation device 3000 is connected to the blood sampling device 3000. The outlet port 3004 further defines an opening to the vise. It may also be connected to tubing or other conduits that are connected to a blood isolation device. Includes hermetic or fluid-tight connectors or connections such as threaded or luer fittings. Thus, as described above, the blood isolation device 3000 can be used with a patient needle and / or Manufactured and sold as a single unit with the tube and blood sample collection device, During blood sampling, the patient needle and the blood sample collection device are connected to the blood isolation device 30 This eliminates the need to connect to 00.

[0159] The blood isolation device 3000 includes a septum between the inlet port 3002 and the outlet port 3004. The pulling channel 3006 and any position between the inlet port 3002 and the outlet port 3004 and a sampling flow path 3006 is connected to the sampling flow path 3006 and separated or separated from the sampling flow path 3006. The sampling channel 3006 further includes a separation chamber 3008 that is converted into a Once the first aliquot of blood has been isolated within the isolation chamber 3008, it functions as a blood collection channel. The sampling channel 3006 may be a channel or conduit of any size, shape, or configuration. In some implementations, the sampling channel 3006 can be In another implementation, the sampling channel 3006 has a cross-sectional area substantially similar to that of the opening. The isolation chamber can gradually expand from the inlet port 3002 to the outlet port 3004. The suction port 3008 is located in the center of the sampling channel 3006, and the blood enters the smaller diameter of the sampling channel 3006. The large reservoir is formed toward the path of the isolation channel so that the It may have a larger cross section.

[0160] In some exemplary implementations, between the sampling channel 3006 and the isolation chamber 3008 The change in direction is due to the diverter branch point 3007. The diverter branch point 3007 is In some preferred exemplary embodiments, the shape of the slit 14 may be substantially Y-shaped, T-shaped, or U-shaped. In this embodiment, as shown in FIGS. 17A to 17B, the diverter branch point 3007 is connected to the inlet port 30. 3002 is preferentially directed to the isolation chamber 3008. The chamber 3008 directs the initial blood flow toward the isolation chamber 3008 and into the isolation chamber 300 8. The device may also include or form a curve or ramp for directing the device into the 8.

[0161] The isolation chamber 3008 is preferably maintained at atmospheric pressure, and the distal portion of the isolation chamber 3008 The vent 3010 may be configured to accommodate air permeable blood as described above. A liquid barrier 3012 may be included.

[0162] The blood isolation device 3000 can be formed from multiple pieces or a single, integral piece. In some implementations, as shown in FIG. 30F, The housing 3001 includes an upper member 3020 and a lower member 3022 that fit together. The blood isolation device 3000 includes an upper member 3020 mechanically attached to a lower member 3022. When the two parts are joined together, the joint between them is sealed by a gasket or sealing member. , a gasket or other sealing member (not shown). A sampling channel 3006, a separation chamber 3008, and a diverter branch point 3007 are formed. To achieve this, the lower part is cut by an injection molding process or by etching, cutting, drilling, etc. Member 3022 may include preformed grooves, channels, locks, conduits, or other pathways. .

[0163] The isolation chamber 3008 prevents blood from entering the smaller diameter of the sampling channel 3006. In contrast, the sampling channel 3006 is arranged so that the particles move preferentially into the isolation chamber first. The cross section may be larger than the cross section of the slit.

[0164] In some implementations, the sampling channel 3006 and the isolation chamber 3008 are disposed within a housing. 3001 is formed by a groove, passage, lock or other path formed in the housing 3 001 can be made of rubber, plastic, metal or any other suitable material. The housing 3001 may be made of a transparent or translucent material, or may be opaque or non-translucent. In other implementations, the housing 3001 can be made of a majority of non-ferrous materials. The sampling channel 3006 and / or the isolation channel may be transparent or non-translucent. The housing surface immediately adjacent member 3008 may be transparent or translucent, and initially a visual cue that the isolation chamber 3008 is filled to the required or desired degree. or sign, and / or the next uncontaminated blood sample is passed through the sampling channel 300 A visual cue or indication that the isolated blood remains isolated while it is being collected through 6 Other visual cues or signs of isolation may include but are not limited to: However, contact with, penetration by, or partial penetration of blood may cause the air permeable blood barrier 3012 to Change to a different color anywhere along or adjacent to the isolation chamber. Including some color-coded tab or indicator, audible signal, vibrating signal, or other signal can be done.

[0165] The air permeable blood barrier 3012 is covered with a cap 3032 or cap 303 2. The cap 3032 prevents air from escaping from the isolation chamber 3008. still allowing air to exit the air permeable blood barrier 3012 as it is expelled from the While the blood is being drawn into the bloodstream, the user may then apply pressure to the air permeable blood barrier 3012 with their finger or other external instrument. The cap 3032 can be sized and configured to prevent contact with the The filter is configured to inhibit or prevent accidental exposure to ambient fluids or splashes. This can include, but is not limited to, adding a hydrophobic membrane to the protective cover. This can be done by a variety of mechanical methods.

[0166] The air venting mechanism at least partially surrounds or surrounds the air permeable blood barrier 3012. The wall 3030 includes a surrounding wall 3030 having one or more air holes formed therein. A cap 3032 covers the wall 3030 and may be snapped, glued, or otherwise secured to the wall 3030. The device can be attached in place by a method such as: A seal 3017 in the form of a material fits within the wall 3030 to form an air permeable blood barrier 3012. The seal 3017 covers the air permeable blood barrier 301 and abuts the top of the wall 3030. 2 and seals it to allow air to pass through the air permeable blood barrier 3012 to the blood isolation chamber 30 08. The fulcrum 3012 on the underside of the cap 3032 prevents the seal 3008 from of the inner wall 3016 when pushed by the air expelled from the blood isolation chamber 3008 The top of the wall 3030 and / or the cap 3032 can be flexibly released to allow air to enter the wall 3030 and / or the cap 3032. 3012 through one or more air holes.

[0167] In use, the blood isolation device 3000 includes a sampling channel 3006 and an isolation chamber 3007. 08. Both paths are initially filled with air at atmospheric pressure, but the sampling path 3006 is a Vacutainer® or other such sealed blood collection device. The air is directed to the outlet port 3004 which is initially sealed, and the isolation chamber 3008 is It terminates in a vent 3010 to atmosphere which contains an air permeable blood barrier 3012 .

[0168] Venipuncture with a patient needle (not shown) that may collect a large number of pathogens from the patient's skin After this, the first volume of the patient's blood carrying these pathogens is introduced into the blood isolation device 3000. This initial volume of potentially contaminated blood passes through the oral port 3002. By finding the path of least resistance, it will preferentially flow into the isolation chamber 3008. The subject's own blood pressure overcomes the atmospheric pressure in the vented isolation chamber 3008, which is air permeable Air in the isolation chamber 3008 is expelled through the blood barrier 3012, but the sealed chamber In various embodiments, the air pressure is insufficient to overcome the air pressure building up in the sampling channel 3006. In the illustrated embodiment, the isolation chamber 3008 and sampling channel 3006 are The force generated by the pressure overcomes the effects of gravity, regardless of the orientation of the blood isolation device. It can be configured to be sufficient.

[0169] Finally, the isolation chamber 3008 is adapted to allow air to pass through the air permeable blood barrier 3012. Once the blood comes into contact with the air-permeable blood barrier, the blood 3012 material to completely or partially vent 3010. Practitioners now have access to Vacutainers or other blood collection devices. A signal or indication may be provided that the device is capable of detecting the presence or absence of a signal.

[0170] After filling the blood isolation pathway 3008, a Vacutainer® or other blood sample Prior to use of the sampling device, the patient's blood pressure is measured by compressing the air in the sampling channel 3006. This may cause a small amount of blood to pass the diversion point and enter the sampling channel 300 6 and wait for uncontaminated blood to be collected through the sampling channel 3006. Put in queue.

[0171] In yet another aspect, the blood isolation chamber and / or The blood collection flow path or other components may provide a visually identifiable warning or may be Suitable for operative fluid communication with a flash chamber of an introducer for an intravenous catheter into a blood vessel. The device and method may provide a plasma-based blood supply to a patient. Visually identifiable warnings when visual changes occur in communication with the responsive test components The reaction with blood or plasma may also include the detection of high levels of blood contents, substances, or their thresholds. or low levels and visually change appearance depending on the results. The blood or plasma may be subjected to one or more reagents disposed therein.

[0172] In yet another aspect, the blood isolation chamber and / or blood collection flow path are adapted to perform the isolation process and / or is sized to provide a specific volumetric flow rate of blood during the sampling process and can be adapted.

[0173] Although various embodiments have been described in detail above, other modifications are possible. may fall within the scope of the following claims.

Claims

1. 1. A blood isolation device comprising: An inlet port; An outlet port; a separation chamber connected to the inlet port via a branch point; a proximal end connected to the inlet port via the branch point and a distal end connected to the outlet port; a sampling channel having a distal end; Including, the isolation chamber having a vent port including an air permeable blood barrier; The vent at least partially surrounds the air permeable blood barrier and includes one or more air defined by an outer wall including an aperture; The vent includes a cap that at least partially covers the outer wall and a vent hole that allows air to pass through the isolation chamber. and a one-way seal adjacent the air permeable blood barrier to prevent blood from entering the blood reservoir. fruit, The isolation chamber, the sampling channel and the branch point are configured such that a first portion of blood the isolation chamber toward the air permeable blood barrier for isolation within the isolation chamber; a second portion of the blood flows into the isolation chamber and a second portion of the blood flows into the isolation chamber and is isolated within the isolation chamber; A first portion of the blood is bypassed and directed to the sampling channel toward the outlet port. The blood isolation device is dimensioned and configured so as to

2. The inlet port, the outlet port, the isolation chamber, and the sampling channel are contained in a The blood isolation device of claim 1 , further comprising a housing defining said blood vessel.

3. The vent further includes an inner wall within the outer wall that includes the air permeable blood barrier.

10. The blood isolation device of claim 1.

4. 2. The method of claim 1, wherein the one-way seal is disposed within the outer wall over an inner wall of the vent.

13. A blood isolation device as described herein.

5. the cap includes an interior surface facing the air permeable blood barrier; The inner surface of the cap includes a fulcrum to allow air to escape from the isolation chamber. and flexibly opening the seal from the air permeable blood barrier relative to the fulcrum. The blood isolation device of claim 4 .

6. The air permeable blood barrier includes a sealing material that seals the vent upon contact with blood.

10. The blood isolation device of claim 1.

7. The air permeable blood barrier includes a filter having a first layer and a second layer, the filter comprising:

10. The blood isolation device of claim 1, wherein the second layer of the filter comprises a hydrophobic material for repelling blood. device.

8. 1. A blood isolation and sampling system comprising: a blood collection pathway having a patient needle at a proximal end and a sample collection device at a distal end; a blood isolation device attached to the blood collection pathway between the proximal end and the distal end of the blood collection pathway; S and Including, The blood isolation device comprises: an inlet port facing the patient needle and connected to the blood collection line; an outlet port facing the sample collection device and connected to the blood collection pathway; a separation chamber connected to the inlet port via a branch point; a proximal end connected to the inlet port via the branch point and a distal end connected to the outlet port; a sampling channel having a distal end; Including, the isolation chamber having a vent port including an air permeable blood barrier; The vent at least partially surrounds the air permeable blood barrier and includes one or more air defined by an outer wall including an aperture; The vent includes a cap that at least partially covers the outer wall and a vent hole that allows air to pass through the isolation chamber. and a one-way seal adjacent the air permeable blood barrier to prevent blood from entering the blood reservoir. 、 The isolation chamber, the sampling channel and the branch point are configured such that a first portion of blood the isolation chamber toward the air permeable blood barrier for isolation within the isolation chamber; a second portion of the blood flows into the isolation chamber and a second portion of the blood flows into the isolation chamber and is isolated within the isolation chamber; A first portion of the blood is bypassed and directed to the sampling channel toward the outlet port.

1. A blood isolation and sampling system, the system being dimensioned and configured so as to

9. The blood isolation device includes the inlet port, the outlet port, the isolation chamber, and The blood sampling system of claim 8 further comprising a housing containing and defining the sampling channel. Isolation system.

10. The blood isolation device has a vent in the outer wall that includes the air permeable blood barrier. The blood isolation system of claim 8 , further comprising an inner wall comprising:

11. a one-way seal for the vent disposed within the outer wall over an inner wall of the vent; The blood isolation system of claim 8.

12. the cap includes an interior surface facing the air permeable blood barrier; The inner surface of the cap includes a fulcrum to allow air to escape from the isolation chamber. and flexibly opening the seal from the air permeable blood barrier relative to the fulcrum. The blood isolation system of claim 11 .

13. The air permeable blood barrier of the blood isolation device seals the vent upon contact with blood.

10. The blood isolation system of claim 8, further comprising a sealing material.

14. The air permeable blood barrier of the blood isolation device includes a filter having a first layer and a second layer. a second layer of the filter having a hydrophobic material for repelling blood. Item 9. The blood isolation system described in item 8.

15. 1. A blood isolation device comprising: An inlet port; An outlet port; a separation chamber connected to the inlet port via a branch point; a proximal end connected to the inlet port via the branch point and a a sampling channel having a distal end; Including, the isolation chamber having a vent that includes an air permeable blood barrier; The vent at least partially surrounds the air permeable blood barrier and includes one or more air defined by an outer wall including an aperture; The vent includes a cap that at least partially covers the outer wall and a vent hole that allows air to pass through the isolation chamber. and a one-way seal adjacent said air permeable blood barrier to prevent blood from entering said cavity. 、 The isolation chamber, the sampling channel and the branch point are configured such that a first portion of blood flowing into the isolation chamber to fill said isolation chamber and venting said isolation chamber through said vent and a second portion of blood flows into the isolation chamber and into the isolation chamber. a first portion of the blood isolated in the isolation chamber and directed toward the outlet port; a blood isolation device sized and configured to be introduced into the sampling flow path.

16. The inlet port, the outlet port, the isolation chamber, and the sampling channel are contained in a The blood isolation device of claim 15 , further comprising a housing defining said blood vessel.

17. The vent further includes an inner wall within the outer wall that includes the air permeable blood barrier.

16. The blood isolation device of claim 15.

18. 16. The one-way seal of claim 15, wherein the one-way seal is disposed within the outer wall over an inner wall of the vent.

2. The blood isolation device according to claim 1 .

19. the cap includes an interior surface facing the air permeable blood barrier; The inner surface of the cap includes a fulcrum to allow air to escape from the isolation chamber. flexibly opening the seal from the air permeable blood barrier relative to the fulcrum.

20. The blood isolation device of claim 18,

20. The air permeable blood barrier includes a sealing material that seals the vent upon contact with blood.

16. The blood isolation device of claim 15.

Citation Information

Patent Citations

  • Single sample needle assemblage

    JP1982089869A

  • Vented phlebotomy needle with flashback chamber

    JP2013240628A

  • Sterile body fluid collection device and method

    JP2016504075A

  • Devices and Methods to Reduce Contamination of Fluid Collected from a Patient

    US20150018715A1